Nichi-Iko Pharmaceutical Co Ltd (4541) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium sulfate, betahistine mesilate tablets, calcium gluconate hydrate powder, candesartan cilexetil tablets and diltiazem hydrochloride table, among others. Its products are used for treatments of circulatory, digestive, respiratory, central and peripheral nervous systems. Nichi-Iko offers manufacturing, sales, distribution, export, import and related activities for various types of pharmaceuticals. The company operates in Sapporo, Sendai, Kanto, Tokai-Hokuriku, Osaka, Hiroshima, Fukuoka, and others. Nichi-Iko is headquartered in Toyama, Japan.

Nichi-Iko Pharmaceutical Co Ltd (4541) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nichi-Iko Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Sagent Pharma Acquires Product Portfolio from Teva Pharma and Actavis for USD40 Million 12
Nichi-Iko Pharma Acquires Pharmaceutical Manufacturing Business from Astellas Pharma Tech 13
Partnerships 14
Lupin and Nichi-Iko Enter into Partnership Agreement 14
Eisai Enters into Agreement with Nichi-Iko Pharma 15
Nichi-Iko Pharma Enters Into Co-Marketing Agreement With Biolab 16
Equity Offering 17
Sagent Pharma Completes Public Offering Of Shares For US$75.3 Million 17
Acquisition 19
Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 19
Sanofi to Sell 4.76% Stake in Nichi-iko Pharma 21
Hong Kong King-Friend Pharmaceutical Acquires 100% Stake in Sagent (China) Pharma From Sagent Pharma 22
Nichi-Iko Pharma Divests 12.6% Stake in Binex for USD50 Million 23
Sagent Pharma Acquires Omega Labs for USD85.3 Million 24
Zhejiang Hisun Pharma Plans to Divest Stake in Sagent Pharma 26
Sagent Pharma Acquires Remaining 50% JV Stake in Kanghong Sagent from Chengdu Kanghong Pharma for USD25 Million 27
Nichi-Iko Pharma Acquires 69% Stake In Yakuhan Pharma 28
Nichi-Iko Pharmaceutical Co Ltd - Key Competitors 29
Nichi-Iko Pharmaceutical Co Ltd - Key Employees 30
Nichi-Iko Pharmaceutical Co Ltd - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 32
Recent Developments 33
Strategy And Business Planning 33
Apr 17, 2018: Nichi-Iko Pharmaceutical: Announcement of completion of new production facility by Aprogen Biologics 33
Financial Announcements 34
Feb 07, 2018: Nichi-Iko Pharmaceutical Reports Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2018 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables


Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nichi-Iko Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Nichi-Iko Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sagent Pharma Acquires Product Portfolio from Teva Pharma and Actavis for USD40 Million 12
Nichi-Iko Pharma Acquires Pharmaceutical Manufacturing Business from Astellas Pharma Tech 13
Lupin and Nichi-Iko Enter into Partnership Agreement 14
Eisai Enters into Agreement with Nichi-Iko Pharma 15
Nichi-Iko Pharma Enters Into Co-Marketing Agreement With Biolab 16
Sagent Pharma Completes Public Offering Of Shares For US$75.3 Million 17
Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 19
Sanofi to Sell 4.76% Stake in Nichi-iko Pharma 21
Hong Kong King-Friend Pharmaceutical Acquires 100% Stake in Sagent (China) Pharma From Sagent Pharma 22
Nichi-Iko Pharma Divests 12.6% Stake in Binex for USD50 Million 23
Sagent Pharma Acquires Omega Labs for USD85.3 Million 24
Zhejiang Hisun Pharma Plans to Divest Stake in Sagent Pharma 26
Sagent Pharma Acquires Remaining 50% JV Stake in Kanghong Sagent from Chengdu Kanghong Pharma for USD25 Million 27
Nichi-Iko Pharma Acquires 69% Stake In Yakuhan Pharma 28
Nichi-Iko Pharmaceutical Co Ltd, Key Competitors 29
Nichi-Iko Pharmaceutical Co Ltd, Key Employees 30
Nichi-Iko Pharmaceutical Co Ltd, Other Locations 31
Nichi-Iko Pharmaceutical Co Ltd, Subsidiaries 32
Nichi-Iko Pharmaceutical Co Ltd, Joint Venture 32

List Of Figures


Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nichi-Iko Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Nichi-Iko Pharmaceutical Co Ltd (4541) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules,

USD 250 View Report

Nichi-Iko Pharmaceutical Co Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Nichi-Iko Pharmaceutical Co Ltd Company Profile is a detailed strategic and analytical report on Nichi-Iko Pharmaceutical Co Ltd. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Xiangxue Pharmaceutical Co Ltd (300147) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The companys products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal

USD 250 View Report

Hunan Fangsheng Pharmaceutical Co Ltd (603998) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hunan Fangsheng Pharmaceutical Co Ltd (Fangsheng Pharma) is a research-based comprehensive pharmaceutical enterprise offers research, development, manufacturing and sales of pharmaceuticals. The enterprise products include tablets, capsules, granules, oral suspension,

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available